Imavita is an innovating technology company dedicated to the exploration of pre-clinical models of human pathologies by the use of innovating imaging techniques and image analysis.
Imavita intends to propose to pharmaceutical industries, biotechnology companies and other private & public laboratories, innovating solutions in efficacy / toxicity evaluation of active ingredients in laboratory species by the use of non invasive imaging techniques and appropriate imaging analysis for quantitative evaluation of specific imaging biomarkers.
Imavita actually proposes the following tools:
- Pre-clinical testing in laboratory species (induction of pathologies / treatment & sampling phases)
- Imaging techniques in vivo non invasive or ex vivo using SPECT/CT, Dual Energy CT, MRI, ultrasonography and more
- Images exploitation and analysis for quantitative imaging
Imavita focus its activities in the following domains:
- Cardiovascular diseases
- Oncology
- Osteo-articular pathologies
- Neurology
- Dermatology
- Drug disposition / PK
Company Details
- Employees
- 12
- Founded
- 2013
- Address
- 3, Rue Des Satellites, Canal Biotech,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- imavita.com
- Keywords
- preclinical models, preclinical imaging, efficacy testing, image analysis, bioinformatics, non clinical testing, cardiovascular, osteo-articular.
- HQ
- Toulouse, Occitanie
Imavita Questions
Imavita's website is imavita.com
Imavita's LinkedIn profile is https://fr.linkedin.com/company/imavita
Imavita has
12 employees.
View email and phone details for 12
employees at Imavita.
Imavita's industry is
Biotechnology Research
Imavita's top competitors are
Olon France,
Antabio,
Physiogenex,
Cell-Easy,
Ysopia Bioscience,
Genoskin,
Twb,
Enterosys - Gut Is The Link,
Dendris,
Ambiotis.
Imavita's categories are Biotechnology Research
Imavita's founding year is 2013
